???global.info.a_carregar???
João Miguel Machado Dória Frazão. Concluiu o(a) Título de Agregado em Medicina em 2023/06/06 pelo(a) Universidade do Porto Faculdade de Medicina, Doutoramento em Medicina em 1999/12/21 pelo(a) Universidade do Porto e Licenciatura em Medicina em 1986/07/31 pelo(a) Universidade NOVA de Lisboa NOVA Medical School. É Professor Associado no(a) Universidade do Porto e Assistente graduado sénior no(a) Centro Hospitalar Universitário de São João. Publicou 92 artigos em revistas especializadas. Possui 2 capítulo(s) de livros. Organizou 8 evento(s). Participou em 13 evento(s). Orientou 5 tese(s) de doutoramento. Orientou 4 dissertação(ões) de mestrado e coorientou 3. Recebeu 9 prémio(s) e/ou homenagens. Atua na(s) área(s) de Ciências Médicas e da Saúde com ênfase em Medicina Clínica com ênfase em Urologia e Nefrologia. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: Activação Neuro-humoral; Osteodistrofia Renal; Nefropatias Hereditárias; Infecção; Neurociência; Infecção e Imunidade; Cancro; Bioengenharia; Saúde; Biomedicina; Ciências Biológicas; Hiperparatiroidismo secundário; hiperfosfatemia; Vitamina D; calcificação vascular; Calcimimeticos; captadores de fósforo; qualidade de vida; doença renal crónica; hemodiálise; Artigos de Investigação; Heart failure with reduced ejection fraction; Hyperkalemia; Novel potassium binders; RAASi optimization; Renin¿angiotensin¿aldosterone system inhibitors; Cardiology and Cardiovascular Medicine; SDG 3 - Good Health and Well-being; chronic kidney disease-mineral bone disease; denosumab; osteoporosis; renal osteodystrophy; romosozumab; teriparatide; Clinical decision-making; Clinical outcomes; Drug therapy; Heart failure; Renin-angiotensin-aldosterone system inhibitors; STAGE RENAL-DISEASE; CORONARY-ARTERY CALCIFICATION; CARDIOVASCULAR RISK; CALCIUM; DIALYSIS; OSTEODYSTROPHY; MORTALITY; STIFFNESS; HISTOMORPHOMETRY; PROGRESSION; Medicine(all); Biochemistry, Genetics and Molecular Biology(all); Agricultural and Biological Sciences(all); Stage Renal-Disease; Coronary-Artery Calcification; Cardiovascular Risk; Calcium; Dialysis; Osteodystrophy; Mortality; Stiffness; Histomorphometry; Progression; Bone-kidney-parathyroid endocrine axis; chronic kidney disease; FGF23; Klotho; phosphate balance; .
Read full resume ↓
Identification

Personal identification

Full name
João Miguel Machado Dória Frazão

Citation names

  • Frazão, João

Author identifiers

Ciência ID
E81B-09DF-8CDC
ORCID iD
0000-0002-8081-5474

Telephones

Mobile phone
  • 919568100 (Professional)

Addresses

  • Faculdade de Medicina da Universidade do Porto - Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Porto, Portugal (Professional)

Knowledge fields

  • Medical and Health Sciences - Clinical Medicine - Urology and Nephrology

Languages

Language Speaking Reading Writing Listening Peer-review
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Portuguese (Mother tongue)
Education
Degree Classification
2023/06/05 - 2023/06/06
Concluded
 Medicina (Título de Agregado)
Major in Medicina
Universidade do Porto Faculdade de Medicina, Portugal
1999/12/21
Concluded
 Medicina (Doutoramento)
Major in Medicina Interna e Nefrologia
Universidade do Porto, Portugal
"Hiperparatiroidismo secundário no doente insuficiente renal crónico terminal em hemodiálise: da patogénese ao tratamento. Uma abordagem mais segura com um novo derivado da Vitamina D" (THESIS/DISSERTATION)
 Aprovado por unanimidade
1980/09/01 - 1986/07/31
Concluded
 Medicina (Licenciatura)
Major in Medicina
Universidade NOVA de Lisboa NOVA Medical School, Portugal
 16
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2009/12/10 - Current Associate Professor (University Teacher) Universidade do Porto, Portugal
Universidade do Porto, Portugal
2000/09/01 - 2009/12/09 Invited Assistant Professor (University Teacher) Universidade do Porto, Portugal

Other Careers

Category
Host institution 		Employer
2016/06/06 - Current Assistente graduado sénior (Médica) Centro Hospitalar Universitário de São João, Portugal
Centro Hospitalar Universitário de São João, Portugal
2012/03/13 - 2016/06/06 Assistente graduado (Médica) Centro Hospitalar Universitário de São João, Portugal
1999/08/05 - 2012/03/13 Assistente (Médica) Centro Hospitalar Universitário de São João, Portugal
Projects

Contract

Designation Funders
2021/01/01 - 2025/12/31 Instituto de Investigação e Inovação em Saúde
LA/P/0070/2020
10.54499/LA/P/0070/2020
Instituto de Astrofísica e Ciências do Espaço, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2019/01/01 - 2019/12/31 Instituto de Investigação e Inovação em Saúde
UID/BIM/04293/2019
Instituto de Astrofísica e Ciências do Espaço, Portugal

Universidade do Porto, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2011/01/01 - 2013/12/31 Projecto Estratégico - UI 725 - 2011-2012
PEst-OE/SAU/UI0725/2011
Universidade do Porto Faculdade de Medicina, Portugal

Universidade do Porto Unidade de Investigação e Desenvolvimento de Nefrologia, Portugal

Hospital de São João, Portugal

Universidade do Porto Faculdade de Medicina Dentária, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book chapter
  1. Pereira, Luciano; Frazão, João M.. "The Role of the Old and the New Calcimimetic Agents in Chronic Kidney Disease-Mineral and Bone Disorder". In Parathyroid Glands in Chronic Kidney Disease, 155-173. Springer International Publishing, 2020.
    Published • 10.1007/978-3-030-43769-5_11
  2. Frazão, J.M. Terapêutica do Hiperparatiroidismo no Doente Urémico. In: Ferreira, A., Frazão, JM., Adragão, T. (eds) 100. "Frazão, J.M. Terapêutica do Hiperparatiroidismo no Doente Urémico". In Ferreira, A., Frazão, JM., Adragão, T. (eds) 100 Perguntas Chave na Nefrologia: Diagnóstico e Terapèutica da Doença Óssea e Metabólica do Doente Urémico, Permanyer Portugal, 48-53. Portugal: Permanyer Portugal, 2019.
    Published
  3. Ferreira, A., Frazão, JM., Adragão, T. (eds) 100 Perguntas Chave na Nefrologia: Diagnóstico e Terapèutica da Doença Ósse. "Ferreira, A., Frazão, JM., Adragão, T. (eds) 100 Perguntas Chave na Nefrologia: Diagnóstico e Terapèutica da Doença Óssea e Metabólica do Doente Urémico, Permanyer Portugal". In Ferreira, A., Frazão, JM., Adragão, T. (eds) 100 Perguntas Chave na Nefrologia: Diagnóstico e Terapèutica da Doença Óssea e Metabólica do Doente Urémico, Permanyer Portugal. Portugal: Permanyer Portugal, 2019.
    Published • Editor
  4. Adragao, Teresa; Ferreira, Aníbal; Frazão, João. "Evaluación no invasiva de la calcificación vascular en pacientes con enfermedad renal crónica". In Alteraciones del metabolismo ósseo Y mineral en la enfermedad renal crónica: avances en patogenia, diagnóstico y tratamento, 159-168. Barcelona, Spain, 2010.
    Published
  5. Cannata-Anadía, J., Frazão, J. Tratamiento de la hiperfosforemia: papel de los captores de fósforo. Alteraciones del met. "Cannata-Anadía, J., Frazão, J. Tratamiento de la hiperfosforemia: papel de los captores de fósforo". In Alteraciones del metabolismo óseo y mineral en la enfermedad renal crónica: avances en patogenia, diagnóstico y tratamento. Wolters Kluwer - Lippincott Williams&Wilkins, 197-208. Wolters Kluwer - Lippincott Williams&Wilkins, 2010.
    Published
  6. Coburn, JW., Frazão, JM. Management of Aluminum Toxicity. In Nissenson AR, Fine RN, eds. Dialysis Therapy, 3rd Edition.. "Management of Aluminum Toxicity. Philadelphia, Hanley & Belfus, Inc". In Nissenson AR, Fine RN, eds. Dialysis Therapy, 405-409. Philadelphia, United States, 2002.
    Published
  7. Frazão, JM., Carrera, F. Doença Glomerular, Síndrome Nefrítica e Síndrome Nefrótica. In Ponce P, ed. Manual de Terapêuti. "Doença Glomerular, Síndrome Nefrítica e Síndrome Nefrótica.". In Ponce P, ed. Manual de Terapêutica Médica, 1ª Edição. Lidel, 2002, 40-50. Portugal: Lidel, 2002.
    Published
  8. Coburn, JW., Frazão, JM. Vitamin D Normal Physiology and Vitamin D Therapeutics in Normal Nutrition and Various Disease. "Coburn, JW., Frazão, JM. Vitamin D Normal Physiology and Vitamin D Therapeutics in Normal Nutrition and Various Disease States". In Morii H, Nishizawa Y, Massry SG, eds. Calcium in Internal Medicine 1st Edition. Springer-Verlag London, 261-305. London, United Kingdom: Springer-Verlag London, 2002.
    Published
  9. Frazao, JM., Coburn, JW. Aluminum Toxicity. In Massry SG, Glassock RJ, eds. Textbook of Nephrology, 4th Edition. Balti. "Frazao, JM., Coburn, JW. Aluminum Toxicity. In Massry SG, Glassock RJ, eds.". In Textbook of Nephrology, 4th Edition. Baltimore, Williams & Wilkins, 1244-1258. 2001.
    Published
  10. Coburn, JW., Maung, HM., Frazao, JM, Elangovan, L. New Vitamin D Analogs and Calcimimetics. In Drüeke T, Salusky I, eds.. "Coburn, JW., Maung, HM., Frazao, JM, Elangovan, L. New Vitamin D Analogs and Calcimimetics. In Drüeke T, Salusky I, eds. The Spectrum of Renal Osteodystrophy, 1th Edition. Oxford University Press". In The Spectrum of Renal Osteodystrophy, 1th Edition. Oxford University Press, 513-531. Oxford, United Kingdom, 2001.
    Published
  11. Carrera, F, Frazão, JM. Thromboembolism and Atheroembolic Disease of the Kidney. In: Schena FP, ed. Textbook of Nephrolo. "Carrera, F, Frazão, JM. Thromboembolism and Atheroembolic Disease of the Kidney". In Schena FP, ed. Textbook of Nephrology, 1st Edition. Mcgraw-Series of Clinical Medicine, 355-359. Mcgraw, 2001.
    Published
  12. Coburn, JW., Frazao, JM. Thromboembolism to the Kidney and Atheroembolic Disease. In: Bone RC. Current Practice of Medi. "Thromboembolism to the Kidney and Atheroembolic Disease". In Bone RC. Current Practice of MedicinEditor Nephrology, Richard J. Glassock, Section Editor. Philadelphia, Current Science, 1541-1545.. 1999.
    Published
  13. Frazão, JM., Coburn, JW. Aluminum Toxicity. In: Llach F, Valderrábano F, eds. Insuficiencia Renal Crónica, Diálisis y T. "Aluminum Toxicity.". In Llach F, Valderrábano F, eds. Insuficiencia Renal Crónica, Diálisis y Trasplante Renal, 375-402. 1997.
    Published
  14. "Divalent Ion Metabolism". In Gonick HC, ed. Current Nephrology, 101-133. 1997.
    Published
Book review
  1. Silva-Cardoso, José; Brito, Dulce; Frazão, João Miguel; Ferreira, Aníbal; Bettencourt, Paulo; Branco, Patrícia; Fonseca, Cândida. "Management of RAASi-associated hyperkalemia in patients with cardiovascular disease". http://hdl.handle.net/10362/113799.
    https://doi.org/10.1007/s10741-020-10069-3
  2. Fonseca, Cândida; Brito, Dulce; Branco, Patrícia; Frazão, João Miguel; Silva-Cardoso, José; Bettencourt, Paulo. "Hipercaliemia e otimização dos inibidores do sistema renina-angiotensina-aldosterona na insuficiência cardíaca crónica com disfunção sistólica". http://hdl.handle.net/10362/147540.
    https://doi.org/10.1016/j.repc.2020.03.015
Journal article
  1. Pereira, L.; Mendonça, L.; Magalhães, J.; Neto, R.; Quelhas-Santos, J.; Oliveira, A.; Beco, A.; Frazão, J.. "Vascular calcification in peritoneal dialysis patients and its association with bone-derived molecules and bone histomorphometry,Calcificación vascular en pacientes en diálisis peritoneal y su asociación con moléculas derivadas de hueso e histomorfometría ósea". Nefrologia (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85182213558&partnerID=MN8TOARS.
    10.1016/j.nefro.2023.01.005
  2. Silva, A.J.B.; Frazão, J.; Pimenta, R.. "Quality of life of people with chronic kidney disease undergoing regular hemodialysis Calidad de vida en personas con insuficiencia renal crónica en programa regular de hemodiálisis,Qualidade de vida na pessoa com insuficiência renal crónica em programa regular de hemodiálise,Qualidade de vida na pessoa com insuficiência renal crónica em programa regular de hemodiálise". Revista de Enfermagem Referencia 6 2 (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85169338892&partnerID=MN8TOARS.
    10.12707/RVI22113
  3. Oliveira-Silva, C.; Marques, N.; Pinho, A.; Poínhos, R.; Bergantim, R.; Nunes, A.T.; Sampaio, S.; et al. "Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement". Nephron 147 3-4 (2023): 158-169. http://www.scopus.com/inward/record.url?eid=2-s2.0-85140248345&partnerID=MN8TOARS.
    10.1159/000525675
  4. Pereira, L.; Mendonça, L.; Magalhães, J.; Neto, R.; Quelhas-Santos, J.; Oliveira, A.; Beco, A.; Frazão, J.. "Vascular calcification in peritoneal dialysis patients and its association with bone-derived molecules and bone histomorphometry,Calcificación vascular en pacientes en diálisis peritoneal y su asociación con moléculas derivadas de hueso e histomorfometría ósea". Nefrologia (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85159056476&partnerID=MN8TOARS.
    10.1016/j.nefroe.2023.05.003
  5. Pereira, L.A.L.; Meng, C.; Amoedo, M.A.G.; Mendes, M.T.D.S.C.P.F.; Marques, M.A.M.P.; Frazão, J.M.M.D.; Weigert, A.L.L.. "Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet,Etelcalcetida controla el hiperparatiroidismo secundario y eleva los niveles de esclerostina en pacientes en hemodiálisis previamente no controlados con cinacalcet". Nefrologia 43 2 (2023): 197-203. http://www.scopus.com/inward/record.url?eid=2-s2.0-85142782856&partnerID=MN8TOARS.
    10.1016/j.nefroe.2022.11.014
  6. Silva,Abílio José Borges; Frazão,João; Pimenta,Rui. "Qualidade de vida na pessoa com insuficiência renal crónica em programa regular de hemodiálise". (2023): http://scielo.pt/scielo.php?script=sci_arttext&pid=S0874-02832023000100233.
  7. Silva, Abílio José Borges; Frazão, João; Pimenta, Rui. "Qualidade de vida na pessoa com insuficiência renal crónica em programa regular de hemodiálise". (2023): https://doi.org/10.12707/RVI22113.
    10.12707/RVI22113,title
  8. Neto R; Pereira L; Magalhães J; Quelhas-Santos J; Frazão J. "Effect of vitamin D sterols on bone histology in pre-dialysis patients: A prospective controlled study.". Clinical nephrology (2022): http://europepmc.org/abstract/med/35200136.
    10.5414/cn110747
  9. Magalhães J; Quelhas-Santos J; Pereira L; Neto R; Castro-Ferreira I; Martins S; Frazão JM; Carvalho C. "Could Bone Biomarkers Predict Bone Turnover after Kidney Transplantation?-A Proof-of-Concept Study.". Journal of clinical medicine (2022): http://europepmc.org/abstract/med/35054152.
    10.3390/jcm11020457
  10. Bover, J.; Trinidad, P.; Jara, A.; Soler-Majoral, J.; Martín-Malo, A.; Torres, A.; Frazão, J.; et al. "Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell,Bodas de plata: 25 años de la primera demostracion del efecto directo del fósforo en la célula paratiroidea". Nefrologia 42 6 (2022): 645-655. http://www.scopus.com/inward/record.url?eid=2-s2.0-85150813239&partnerID=MN8TOARS.
    10.1016/j.nefroe.2023.02.008
  11. Pereira, L.; Magalhães, J.; Mendonça, L.; Neto, R.; Santos, J.; Carvalho, C.G.; Oliveira, A.; Beco, A.; Frazão, J.. "Evaluation of Renal Osteodystrophy and Serum Bone-Related Biomarkers in a Peritoneal Dialysis Population". Journal of Bone and Mineral Research (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85133467620&partnerID=MN8TOARS.
    10.1002/jbmr.4636
  12. Díaz-Tocados, J.M.; Rodríguez-Ortiz, M.E.; Almadén, Y.; Carvalho, C.; Frazão, J.M.; Rodríguez, M.; Muñoz-Castañeda, J.R.. "Effect of a calcium-rich diet on mineral and bone metabolism in rats". Revista de Osteoporosis y Metabolismo Mineral 14 1 (2022): 48-54. http://www.scopus.com/inward/record.url?eid=2-s2.0-85147015548&partnerID=MN8TOARS.
    10.4321/S1889-836X2022000100006
  13. "Improvements in six aspects of quality of care of incident hemodialysis patients – a real-world experience". BMC Nephrology 22 1 (2021): http://dx.doi.org/10.1186/s12882-021-02529-1.
    10.1186/s12882-021-02529-1
  14. "Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4". Clinical Kidney Journal 14 11 (2021): 2401-2408. http://dx.doi.org/10.1093/ckj/sfab081.
    10.1093/ckj/sfab081
  15. "Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet". Nefrología (2021): http://dx.doi.org/10.1016/j.nefro.2021.09.009.
    10.1016/j.nefro.2021.09.009
  16. "Low bone turnover is associated with plain X-ray vascular calcification in predialysis patients". PLOS ONE 16 10 (2021): e0258284-e0258284. http://dx.doi.org/10.1371/journal.pone.0258284.
    10.1371/journal.pone.0258284
  17. "Management of RAASi-associated hyperkalemia in patients with cardiovascular disease". Heart Failure Reviews 26 4 (2021): 891-896. http://dx.doi.org/10.1007/s10741-020-10069-3.
    10.1007/s10741-020-10069-3
  18. Fonseca C; Brito D; Branco P; Frazão JM; Silva-Cardoso J; Bettencourt P. "Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review.". Revista portuguesa de cardiologia (2020): http://europepmc.org/abstract/med/32868174.
    10.1016/j.repc.2020.03.015
  19. Pereira L; Frazão JM. "The bone-vessel axis in chronic kidney disease: An update on biochemical players and its future role in laboratory medicine.". Clinica chimica acta; international journal of clinical chemistry (2020): http://europepmc.org/abstract/med/32422129.
    10.1016/j.cca.2020.05.023
  20. Pereira,Ana Beatriz de Oliveira; Frazão,João Miguel Machado Dória. "Kidney-induced osteoporosis: a new entity with a novel therapeutic approach". (2020): http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692020000200005.
  21. Fonseca, Cândida; Brito, Dulce; Branco, Patrícia; Frazão, João; Silva-Cardoso, José; Bettencourt, Paulo. "Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction : a systematic review". (2020): http://hdl.handle.net/10451/44604.
    10.1016/j.repc.2020.03.015
  22. Neto R; Frazão J. "Efficacy and safety of calcium carbonate in normophosphataemic patients with chronic kidney disease Stages 3 and 4.". Clinical kidney journal (2019): http://europepmc.org/abstract/med/33623678.
    10.1093/ckj/sfz181
  23. Weigert A; Drozdz M; Silva F; Frazão J; Alsuwaida A; Krishnan M; Kleophas W; et al. "Influence of gender and age on haemodialysis practices: a European multicentre analysis.". Clinical kidney journal (2019): http://europepmc.org/abstract/med/32296527.
    10.1093/ckj/sfz069
  24. Díaz-Tocados JM; Rodríguez-Ortiz ME; Almadén Y; Pineda C; Martínez-Moreno JM; Herencia C; Vergara N; et al. "Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.". Kidney international (2019): http://europepmc.org/abstract/med/30878213.
    10.1016/j.kint.2018.12.015
  25. Drozdz M; Weigert A; Silva F; Frazão J; Alsuwaida A; Krishnan M; Kleophas W; et al. "Achievement of renal anemia KDIGO targets by two different clinical strategies - a European hemodialysis multicenter analysis.". BMC nephrology (2019): http://europepmc.org/abstract/med/30616548.
    10.1186/s12882-018-1196-7
  26. Ureña-Torres PA; Vervloet M; Mazzaferro S; Oury F; Brandenburg V; Bover J; Cavalier E; et al. "Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease.". Clinical kidney journal (2018): http://europepmc.org/abstract/med/30976408.
    10.1093/ckj/sfy061
  27. Aguiar F; Meng C; Pereira L; Brito I; Frazão JM. "Bone biopsy: an ally in the management of fragility fractures in chronic kidney disease.". Acta reumatologica portuguesa (2018): http://europepmc.org/abstract/med/30414368.
  28. Aguiar, F.R.; Meng, C.; Pereira, L.; Brito, I.; Frazão, J.M.. "Bone biopsy: An ally in the management of fragility fractures in chronic kidney disease". Acta Reumatologica Portuguesa 2018 3 (2018): 201-209. http://www.scopus.com/inward/record.url?eid=2-s2.0-85055923286&partnerID=MN8TOARS.
  29. Pereira L; Meng C; Marques D; Frazão JM. "Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes.". Clinical kidney journal (2017): http://europepmc.org/abstract/med/29423207.
    10.1093/ckj/sfx125
  30. Diaz-Tocados, J.M.; Peralta-Ramirez, A.; Rodríguez-Ortiz, M.E.; Raya, A.I.; Lopez, I.; Pineda, C.; Herencia, C.; et al. "Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats". Kidney International 92 5 (2017): 1084-1099. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026446465&partnerID=MN8TOARS.
    10.1016/j.kint.2017.04.011
  31. Meng, C.; Martins, P.; Frazão, J.; Pestana, M.. "Parathyroidectomy in Persistent Post-transplantation Hyperparathyroidism — Single-center Experience". Transplantation Proceedings 49 4 (2017): 795-798. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018355809&partnerID=MN8TOARS.
    10.1016/j.transproceed.2017.01.067
  32. Adragao, T.; Ferreira, A.; Frazao, J.M.; Papoila, A.L.; Pinto, I.; Monier-Faugere, M.-C.; Malluche, H.H.. "Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients". PLoS ONE 12 7 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85022183209&partnerID=MN8TOARS.
    10.1371/journal.pone.0179868
  33. Carvalho, C.; Magalhães, J.; Neto, R.; Pereira, L.; Branco, P.; Adragão, T.; Frazão, J.M.. "Cortical bone analysis in a predialysis population: a comparison with a dialysis population". Journal of Bone and Mineral Metabolism 35 5 (2017): 513-521. http://www.scopus.com/inward/record.url?eid=2-s2.0-84994476532&partnerID=MN8TOARS.
    10.1007/s00774-016-0781-8
  34. Adragao, Teresa; Ferreira, Anibal; Frazao, Joao M.; Papoila, Ana Luisa; Pinto, Iola; Monier-Faugere, Marie Claude; Malluche, Hartmut H.. "Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients". (2017): https://doi.org/10.1371/journal.pone.0179868.
    10.1371/journal.pone.0179868,title
  35. Adragao, Teresa; Ferreira, Anibal; Frazão, João; Papoila, Ana Luisa; Pinto, Iola; Monier-Faugere, Marie-Claude; Malluche, Hartmut H.. "Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients". (2017): http://hdl.handle.net/10400.21/7587.
    10.1371/journal.pone.0179868
  36. Carvalho, C.; Magalhães, J.; Pereira, L.; Simóes-Silva, L.; Castro-Ferreira, I.; Frazão, J.M.. "Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone". Nephrology 21 1 (2016): 55-61. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951816935&partnerID=MN8TOARS.
    10.1111/nep.12570
  37. Carvalho, C.; Alves, C.M.; Frazão, J.M.. "The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives". Journal of Nephrology 29 5 (2016): 617-626. http://www.scopus.com/inward/record.url?eid=2-s2.0-84987746814&partnerID=MN8TOARS.
    10.1007/s40620-016-0339-9
  38. Oliveira TM; Frazão JM. "Calciphylaxis: from the disease to the diseased.". (2015): http://europepmc.org/abstract/med/25835730.
    10.1007/s40620-015-0192-2
  39. Carvalho C; Magalhães J; Pereira L; Simões-Silva L; Castro-Ferreira I; Frazão JM. "Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone.". (2015): http://europepmc.org/abstract/med/26201946.
  40. Parfrey, P.S.; Drüeke, T.B.; Block, G.A.; Correa-Rotter, R.; Floege, J.; Herzog, C.A.; London, G.M.; et al. "The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial". Clinical Journal of the American Society of Nephrology 10 5 (2015): 791-799. http://www.scopus.com/inward/record.url?eid=2-s2.0-84929171843&partnerID=MN8TOARS.
    10.2215/CJN.07730814
  41. Palmer, S.C.; Ruospo, M.; Campbell, K.L.; Larsen, V.G.; Saglimbene, V.; Natale, P.; Gargano, L.; et al. "Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: Protocol for DIET-HD, a prospective multinational cohort study". BMJ Open 5 3 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84926442249&partnerID=MN8TOARS.
    10.1136/bmjopen-2014-006897
  42. Brandenburg, V.; Adragao, T.; Dam, B.V.; Evenepoel, P.; Frazão, J.M.; Ketteler, M.; Mazzaferro, S.; et al. "Blueprint for a European calciphylaxis registry initiative: The European calciphylaxis Network (EuCalNet)". Clinical Kidney Journal 8 5 (2015): 567-571. http://www.scopus.com/inward/record.url?eid=2-s2.0-84954047825&partnerID=MN8TOARS.
    10.1093/ckj/sfv056
  43. Moe, S.M.; Chertow, G.M.; Parfrey, P.S.; Kubo, Y.; Block, G.A.; Correa-Rotter, R.; Drüeke, T.B.; et al. "Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial". Circulation 132 1 (2015): 27-39. http://www.scopus.com/inward/record.url?eid=2-s2.0-84935451711&partnerID=MN8TOARS.
    10.1161/CIRCULATIONAHA.114.013876
  44. Diniz, H.; Frazão, J.M.. "The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder". Nefrología : publicación oficial de la Sociedad Española Nefrologia 33 6 (2013): 835-844. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922282266&partnerID=MN8TOARS.
    10.3265/Nefrologia.pre2013.Jul.12091
  45. Diniz, H.; Frazão, J.M.. "The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder". Nefrologia 33 6 (2013): 835-844. http://www.scopus.com/inward/record.url?eid=2-s2.0-84889077192&partnerID=MN8TOARS.
    10.3265/Nefrologia.pre2013.Sep.12162
  46. Frazão, J.M.; Braun, J.; Messa, P.; Dehmel, B.; Mattin, C.; Wilkie, M.. "Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?". BMC Nephrology 13 1 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84867552878&partnerID=MN8TOARS.
    10.1186/1471-2369-13-76
  47. Frazo, J.M.; Adrago, T.. "Non-calcium-containing phosphate binders: Comparing efficacy, safety, and other clinical effects". Nephron - Clinical Practice 120 2 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84860551438&partnerID=MN8TOARS.
    10.1159/000337087
  48. Chertow, G.M.; Block, G.A.; Correa-Rotter, R.; Drüeke, T.B.; Floege, J.; Goodman, W.G.; Herzog, C.A.; et al. "Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis". New England Journal of Medicine 367 26 (2012): 2482-2494. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871675923&partnerID=MN8TOARS.
    10.1056/NEJMoa1205624
  49. Adragão,Teresa; Frazão,João M.. "Phosphate balance in chronic kidney disease?: the chicken or the egg". (2012): http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692012000200003.
  50. Frazão JM; Messa P; Mellotte GJ; Geiger H; Hagen EC; Quarles LD; Kerr PG; et al. "Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.". (2011): http://europepmc.org/abstract/med/21888861.
  51. Frazão, J.M.; Messa, P.; Mellotte, G.J.; Geiger, H.; Hagen, E.C.; Quarles, L.D.; Kerr, P.G.; et al. "Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity". Clinical Nephrology 76 3 (2011): 233-243. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052536028&partnerID=MN8TOARS.
    10.5414/CN106965
  52. Roncon-Albuquerque R Jr; Beco A; Ferreira AL; Gomes-Carvalho C; Costa A; Frazão J; Pestana M; von Hafe P. "Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis.". (2010): http://europepmc.org/abstract/med/20353743.
  53. Adragao, T.; Herberth, J.; Monier-Faugere, M.-C.; Branscum, A.J.; Ferreira, A.; Frazao, J.M.; Malluche, H.H.. "Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients". Osteoporosis International 21 4 (2010): 619-625. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950929095&partnerID=MN8TOARS.
    10.1007/s00198-009-0988-9
  54. Martins RG; Roncon-Albuquerque R Jr; Cabral R; Frazão J; Von Hafe P. "[Primary amyloidosis associated with kappa light chain myeloma].". (2010): http://europepmc.org/abstract/med/20470479.
  55. Martins, R.G.; Roncon-Albuquerque Jr., R.; Cabral, R.; Frazão, J.; Von Hafe, P.. "Primary amyloidosis associated with kappa light chain myeloma | Amiloidose primária associado a mieloma de cadeias leves kappa". Acta Medica Portuguesa 23 2 (2010): 281-284. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953375645&partnerID=MN8TOARS.
  56. Roncon-Albuquerque Jr., R.; Beco, A.; Ferreira, A.L.; Gomes-Carvalho, C.; Costa, A.; Frazão, J.; Pestana, M.; Von Hafe, P.. "Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis". Clinical Nephrology 73 4 (2010): 326-330. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950855887&partnerID=MN8TOARS.
  57. Martins, Raquel G; Roncon-Albuquerque, Roberto; Cabral, Raquel; Frazão, João; Von Hafe, Pedro. "Primary amyloidosis associated with kappa light chain myeloma.". (2010): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/603.
  58. Wilkie, M.; Pontoriero, G.; MacÁrio, F.; Yaqoob, M.; Bouman, K.; Braun, J.; Von Albertini, B.; et al. "Impact of vitamin d dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet". Nephron - Clinical Practice 112 1 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-64149117771&partnerID=MN8TOARS.
    10.1159/000212102
  59. Adragao, T.; Herberth, J.; Monier-Faugere, M.-C.; Branscum, A.J.; Ferreira, A.; Frazao, J.M.; Curto, J.D.; Malluche, H.H.. "Low bone volume - A risk factor for coronary calcifications in hemodialysis patients". Clinical Journal of the American Society of Nephrology 4 2 (2009): 450-455. http://www.scopus.com/inward/record.url?eid=2-s2.0-66849101767&partnerID=MN8TOARS.
    10.2215/CJN.01870408
  60. Frazão, J.M.; Martins, P.. "Adynamic bone disease: clinical and therapeutic implications". Current Opinion in Nephrology and Hypertension 18 4 (2009): 303-307. http://www.scopus.com/inward/record.url?eid=2-s2.0-67849096870&partnerID=MN8TOARS.
    10.1097/MNH.0b013e32832c4df0
  61. Covic, A.; Cannata-Andia, J.; Cancarini, G.; Coppo, R.; Frazão, J.M.; Goldsmith, D.; Ronco, P.; et al. "Biosimilars and biopharmaceuticals: What the nephrologists need to know - A position paper by the ERA-EDTA Council". Nephrology Dialysis Transplantation 23 12 (2008): 3731-3737. http://www.scopus.com/inward/record.url?eid=2-s2.0-56749163625&partnerID=MN8TOARS.
    10.1093/ndt/gfn519
  62. Frazão, J.M.; Adragão, T.. "Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: Effects on vascular calcification, bone and a close look into the survival data". Kidney International 74 SUPPL. 111 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-57049173903&partnerID=MN8TOARS.
    10.1038/ki.2008.544
  63. Frazão, J.; Rodriguez, M.. "Secondary hyperparathyroidism disease stabilization following calcimimetic therapy". NDT Plus 1 SUPPL.1 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-39449129617&partnerID=MN8TOARS.
    10.1093/ndtplus/sfm039
  64. Messa, P.; Macário, F.; Yaqoob, M.; Bouman, K.; Braun, J.; von Albertini, B.; Brink, H.; et al. "The OPTIMA study: Assessing a new cincalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism". Clinical Journal of the American Society of Nephrology 3 1 (2008): 36-45. http://www.scopus.com/inward/record.url?eid=2-s2.0-38749101028&partnerID=MN8TOARS.
    10.2215/CJN.03591006
  65. Adragão, T.; Frazão, J.M.. "Cardiovascular risk in dialysis patients: An X-ray vision on vascular calcifications". Kidney International 74 12 (2008): 1505-1507. http://www.scopus.com/inward/record.url?eid=2-s2.0-57049122819&partnerID=MN8TOARS.
    10.1038/ki.2008.503
  66. Martins, P.; Schmitt, F.; Almeida, H.; Frazão, J.M.. "Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism". Nephrology Dialysis Transplantation 23 9 (2008): 2889-2894. http://www.scopus.com/inward/record.url?eid=2-s2.0-58549085984&partnerID=MN8TOARS.
    10.1093/ndt/gfn150
  67. Malluche, H.H.; Monier-Faugere, M.-C.; Wang, G.; Frazão, J.M.; Charytan, C.; Coburn, J.W.; Coyne, D.W.; et al. "An assessment of cinacalcet HCI effects on bone histology in dialysis patients with secondary hyperparathyroidism". Clinical Nephrology 69 4 (2008): 269-277. http://www.scopus.com/inward/record.url?eid=2-s2.0-42049115865&partnerID=MN8TOARS.
  68. Ferreira, A.; Frazão, J.M.; Monier-Faugere, M.-C.; Gil, C.; Galvao, J.; Oliveira, C.; Baldaia, J.; et al. "Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients". Journal of the American Society of Nephrology 19 2 (2008): 405-412. http://www.scopus.com/inward/record.url?eid=2-s2.0-39049125268&partnerID=MN8TOARS.
    10.1681/ASN.2006101089
  69. Ureña P; Frazão JM. "Calcimimetic agents: review and perspectives.". (2003): http://europepmc.org/abstract/med/12753275.
  70. Ureña, P.; Frazão, J.M.. "Calcimimetic agents: Review and perspectives". Kidney International, Supplement 63 85 (2003): http://www.scopus.com/inward/record.url?eid=2-s2.0-0037512520&partnerID=MN8TOARS.
    10.1046/j.1523-1755.63.s85.22.x
  71. Frazão JM; Martins P; Coburn JW. "The calcimimetic agents: perspectives for treatment.". (2002): http://europepmc.org/abstract/med/11982829.
  72. Frazão, J.M.; Martins, P.; Coburn, J.W.. "The calcimimetic agents: Perspectives for treatment". Kidney International, Supplement 61 80 (2002): http://www.scopus.com/inward/record.url?eid=2-s2.0-0035999938&partnerID=MN8TOARS.
  73. Maung HM; Elangovan L; Frazão JM; Bower JD; Kelley BJ; Acchiardo SR; Rodriguez HJ; et al. "Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.". (2001): http://europepmc.org/abstract/med/11228177.
    10.1053/ajkd.2001.22077
  74. Maung, H.M.; Elangovan, L.; Frazão, J.M.; Bower, J.D.; Kelley, B.J.; Acchiardo, S.R.; Rodriguez, H.J.; et al. "Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1a-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison". American Journal of Kidney Diseases 37 3 (2001): 532-543. http://www.scopus.com/inward/record.url?eid=2-s2.0-17144459471&partnerID=MN8TOARS.
  75. Frazão JM; Elangovan L; Maung HM; Chesney RW; Acchiardo SR; Bower JD; Kelley BJ; et al. "Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.". (2000): http://europepmc.org/abstract/med/10977787.
    10.1053/ajkd.2000.16193
  76. Frazão, J.M.; Elangovan, L.; Maung, H.M.; Chesney, R.W.; Acchiardo, S.R.; Bower, J.D.; Kelley, B.J.; et al. "Intermittent doxercalciferol (1a-hydroxyvitamin d2) therapy for secondary hyperparathyroidism". American Journal of Kidney Diseases 36 3 (2000): 550-561. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033624518&partnerID=MN8TOARS.
  77. Goodman, W.G.; Frazao, J.M.; Goodkin, D.A.; Turner, S.A.; Liu, W.; Coburn, J.W.. "A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism". Kidney International 58 1 (2000): 436-445. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033935152&partnerID=MN8TOARS.
    10.1046/j.1523-1755.2000.00183.x
  78. Coburn JW; Elangovan L; Goodman WG; Frazaõ JM. "Calcium-sensing receptor and calcimimetic agents.". Kidney international. Supplement (1999): http://europepmc.org/abstract/med/10633465.
    10.1046/j.1523-1755.1999.07303.x
  79. Coburn, J.W.; Elangovan, L.; Goodman, W.G.; Frazaõ, J.M.. "Calcium-sensing receptor and calcimimetic agents". Kidney International, Supplement 56 73 (1999): http://www.scopus.com/inward/record.url?eid=2-s2.0-0033372296&partnerID=MN8TOARS.
  80. Cannata-Andia, J.B.; Harrington, J.T.; Martinez-Maldonado, M.; Massari, P.; Schor, N.; Carlos Ayus, J.; Valderrabano, F.; et al. "Hypokinetic azotemic osteodystrophy". Kidney International 54 3 (1998): 1000-1016. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031714473&partnerID=MN8TOARS.
    10.1046/j.1523-1755.1998.00080.x
  81. Frazão, J.M.; Elangovan, L.; Felsenfeld, A.J.; Stanley, T.M.; Cohen, A.H.. "Epstein-Barr-virus-induced interstital nephritis in an HIV-positive patient with progressive renal failure". Nephrology Dialysis Transplantation 13 7 (1998): 1849-1852. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031801877&partnerID=MN8TOARS.
    10.1093/ndt/13.7.1849
  82. Frazao, J.M.; Chesney, R.W.; Coburn, J.W.. "Intermittent oral 1a-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients". Nephrology Dialysis Transplantation 13 SUPPL. 3 (1998): 68-72. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031637872&partnerID=MN8TOARS.
    10.1093/ndt/13.suppl_3.68
  83. Frazao, J.M.; Levine, B.S.; Tan Jr., A.U.; Mazess, R.B.; Kyllo, D.M.; Knutson, J.C.; Bishop, C.W.; Coburn, J.W.. "Efficacy and safety of intermittent oral 1a(OH)-vitamin D2 in suppressing 2° hyperparathyroidism in hemodialysis patients". Dialysis and Transplantation 26 9 (1997): 583-595+630. http://www.scopus.com/inward/record.url?eid=2-s2.0-0000850317&partnerID=MN8TOARS.
  84. Coburn, J.W.; Frazao, J.. "Calcitriol in the management of renal osteodystrophy". Seminars in Dialysis 9 4 (1996): 316-326. http://www.scopus.com/inward/record.url?eid=2-s2.0-0001339737&partnerID=MN8TOARS.
  85. Frazao J; Coburn JW. "Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.". American journal of kidney diseases : the official journal of the National Kidney Foundation (1995): http://europepmc.org/abstract/med/7485141.
    10.1016/0272-6386(95)90452-2
  86. Frazao JM; Barth RH; Berlyne GM. "Carbamylated hemoglobin in prerenal azotemia.". Nephron (1995): http://europepmc.org/abstract/med/8569946.
    10.1159/000188704
  87. Frazao, J.; Coburn, J.W.. "Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: Value of bone biopsy in the diagnosis and management". American Journal of Kidney Diseases 26 5 (1995): 831-835. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028841262&partnerID=MN8TOARS.
  88. Frazao, J.M.; Barth, R.H.; Berlyne, G.M.. "Carbamylated hemoglobin in prerenal azotemia". Nephron 71 2 (1995): 153-155. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029145845&partnerID=MN8TOARS.
  89. Carrera F; Silva JG; Oliveira C; Frazao JM; Pires C. "Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population.". Nephron (1994): http://europepmc.org/abstract/med/7527504.
    10.1159/000188084
  90. Carrera, F.; Silva, J.G.; Olivieira, C.; Frazao, J.M.; Pires, C.. "Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population". Nephron 68 1 (1994): 38-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027998366&partnerID=MN8TOARS.
  91. Oliveira C; Frazão JM; Pires C; Silva JG; Carrera F. "[Significance of digestive hemorrhage in patients with chronic renal insufficiency in hemodialysis]". (1992): http://europepmc.org/abstract/med/1595370.
  92. Oliveira, C.; Frazão, J.M.; Pires, C.; Silva, J.G.; Carrera, F.. "Significance of digestive hemorrhage in patients with chronic renal insufficiency in hemodialysis | Importância da hemorragia digestiva nos doentes com insuficiência renal crónica em hemodiálise.". Acta medica portuguesa 5 2 (1992): 71-74. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026810952&partnerID=MN8TOARS.
Thesis / Dissertation
  1. Frazão, João Miguel Machado Dória. "Hiperparatiroidismo secundário no doente insuficiente renal crónico terminal em hemodiálise : Da patogenese ao tratamento : Uma Abordagem mais segura com um novo derivado da vitamina D". PhD, 1999. http://hdl.handle.net/10216/9950.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2020/06/06 The spectrum of renal osteodystrophy in prevalent peritoneal dialysis patients in 21st century - a histomorphometric analysis of bone biopsies. L Pereira, J Magalhães, R Neto, A Oliveira, A Beco, J Frazão. Comunicação oral
2020/06/06 Vascular Calcification in prevalent peritoneal dialysis patients and its relationship with clinical and bone histomorfometric parameters. L Pereira, J Magalhães, R Neto, A Oliveira, A Beco, J Frazão. Comunicação oral
2019/10/05 Efectos diferenciales del calcitriol y calcimimético sobre el metabolismo óseo y mineral en la enfermedad renal. JM Días-Tocados, ME Rodríguez Ortiz, Y Almadén, C Pineda Martos, MV Ruíz de Mier, JM Frazão, E Tejero, I Villalba, JR Castañeda, M Portillo. Comunicação oral
(Coruña, Spain)
2019/10/05 En estadíos tempranos de enfermedad renal crónica el exceso de FGF23 incrementa el remodelado óseo y retrasa la maduración de osteoblastos. JR Muñoz-Castañeda, JM Díaz-Tocados, ME Rodríguez-Ortiz, Y Almaden, R López Baltanás, C Membrives, C Carvalho, J Frazão, M Rodríguez. Comunicação oral
(Coruña, Spain)
2019/10/05 “Manejo de la osteoporosis en pacientes con enfermedad renal” João M. Frazão Palestra
(Coruña, Spain)
2019/04/05 “Secondary hyperparahyroidism: clinical consequences and new therapies” João M. Frazão Palestra
(Porto, Portugal)
2019/03/28 “Patirómero: mudar o paradigma do tratamento da hipercaliémia” João M. Frazão Palestra
(Vilamoura, Portugal)
2018/09/13 “The Bone-vessel axis”. João M. Frazão Palestra
(Thessaloniki, Greece)
2018/05/24 “Are all phosphate binders the same for CKD patients?” João M. Frazão Palestra
(Copenhaga, Denmark)
2018/05/24 “Novel approaches to treat renal osteodystrophy” João M. Frazão Palestra
(Copenhaga, Denmark)
2018/01/27 “Quais os desafios do novo calcimimético?” João M. Frazão Palestra
(Figueira da Foz, Portugal)
2017/10/06 En ratas urémicas la adición de calcimimético incrementa el remodelado óseo independientemente de su acción sobre la PTH. JM Tocados, M Rodriguez Ortiz, Y Almadén, V Lorenzo, J Frazão, E Tejero, I López, JR Castañeda, M Rodriguez. Comunicação oral
(Burgos, Spain)
2017/09/08 “Old and new calcimimetics” João M. Frazão Palestra
(Paris, France)
2017/06/03 Types of renal osteodystrophy in a portuguese pre-dialysis cohort. R Neto, L Pereira, C Carvalho, J Magalhães, C Meng, J Frazão. Comunicação oral
(Madrid, Spain)
2017/05/10 “Diabetes e rim. Como travar a progressão da insuficiência renal: papel dos novos fármacos”. João M. Frazão Palestra
(Albufeira, Portugal)
2017/02/04 “Doença mineral e óssea nos doentes renais crónicos em diálise peritoneal”. João M. Frazão Palestra
(Figueira da Foz, Portugal)
2016/01/30 “Tratamento médico do hiperparatiroidismo secundário: Uma actualização e análise no seu impacto clínico”. João M. Frazão Palestra
(Curia, Portugal)
2006/07/15 Vascular calcifications and bone turnover in hemodialysis patients. Adragão T, Ferreira A, Frazão JM, Gil C, Oliveira C, Galvão J, Sarmento M, Ribeiro S, Dickson J, Carvalho B, Rodrigues I, Baldaia J, Pereira O, Faugere MC, Malluche HH. Comunicação oral
(Glasgow, United Kingdom)
2006/07/15 Effects of sevelamer and calcium carbonate on boné mineralization and turnover in chronic maintenance haemodialysis patients. Ferreira A, Frazão JM, Faugere MC, Mueller R, Malluche HH. Comunicação oral
(Glasgow, United Kingdom)
2006/07/15 Early use of cinacalcet (Mimpara®/Sensipar®) in dialysis patients enables greatest achievement of NKF-KDOQITM treatment targets for bone metabolism. Frazão JM, Messa P, Cunningham J, Evenepoel P, Shahapuni I, Urena P, Braun J, Zani V, Banos A, Molemans B, de Francisco ALM. Comunicação oral
(Glasgow, United Kingdom)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2024/01/01 - Current Avaliação da expressão de factores angiogénicos e dos seus níveis plasmáticos em lesões proliferativas da glândula paratiróide nos doentes com Doença Renal Crónica e Hiperparatiroidismo Secundário
Supervisor
Universidade do Porto, Portugal
2012/09/01 - Current Caracterização histomorfométrica da osteodistrofia renal em doentes sob diálise peritoneal
Supervisor
Universidade do Porto, Portugal
2023/06/21 - 2023/06/21 Acesso de diálise no doente renal crónico: implicações clínicas e económicas
Supervisor
Universidade do Porto, Portugal
2022/10/11 - 2022/10/11 Distúrbio do Metabolismo Mineral e Ósseo Associado à Doença Renal Crónica em fase Pré-Dialítica
Supervisor
Universidade do Porto, Portugal
2021/06/17 - 2021/06/17 Podocitopatia lúpica: uma visão geral sobre esta nova variante histológica
Co-supervisor
2021/05/28 - 2021/05/28 Evolution of circulating bone related biomarkers after kidney transplantation
Co-supervisor
2021/05/27 - 2021/05/27 Novos agentes redutores do potássio na abordagem da hipercalemia na doença renal crónica
Co-supervisor
2021/05/20 - 2021/05/20 Vitamin K in hemodialysis patients
Supervisor
2020/05/26 - 2020/05/26 Kidney-induced osteoporosis: a new entity with a novel therapeutic approach
Supervisor
2018/06/05 - 2018/06/05 The role of Klotho in CKD progression
Supervisor
2017/02/03 - 2017/02/03 Osteodistrofia renal: Estudo histomorfométrico de diferentes populações de doentes renais. Importância da avaliação do osso cortical
Supervisor
Universidade do Porto, Portugal
2005/09/01 - 2005/09/01 Angiogénese da Glândula Paratiróide no Hiperparatiroidismo Secundário
Supervisor
Universidade do Porto, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2018/01/27 - 2018/01/27 6th CKD-MBD Made in Portugal (2018/01/27 - 2018/01/27)
Congress (Member of the Organising Committee)
2017/04/06 - 2017/04/08 Encontro Renal 2017 (2017/04/06 - 2017/04/08)
Congress (President of the Organising Committee)
2017/02/04 - 2017/02/04 5th CKD-MBD Made in Portugal (2017/02/04 - 2017/02/04)
Congress (Member of the Organising Committee)
2016/04/13 - 2016/04/16 Encontro Renal 2016 (2016/04/13 - 2016/04/16)
2016/01/30 - 2016/01/30 4th CKD-MBD Made in Portugal (2016/01/30 - 2016/01/30)
Congress (Member of the Organising Committee)
2015/01/31 - 2015/01/31 3rd CKD-MBD Made in Portugal (2015/01/31 - 2015/01/31)
Congress (Member of the Organising Committee)
2014/02/01 - 2014/02/01 2nd CKD-MBD Made in Portugal (2014/02/01 - 2014/02/01)
Congress (Member of the Organising Committee)
2005/10/13 - 2005/10/13 XIX Congresso Português de Nefrologia (2005/10/13 - 2005/10/13)
Congress (Member of the Organising Committee)

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2020/10/26 - 2020/10/30 Tratamento do hiperparatiroidismo secundário com etelcalcetido - a experiência da conversão de cinacalcet para etelcalcetido numa unidade de hemodiálise portuguesa¿. L Pereira, A Azevedo, J Frazão. Poster
Congress
2020/10/26 - 2020/10/30 Acute kidney injury associated with membranoproliferative glomerulonephritis in the setting of lead-dependent infective endocarditis - a case report. N Marques, H Diniz, R Silva, M Relvas, A Oliveira, L Coentrão, F Macedo, J Frazão. Poster
Congress
2020/06/06 - 2020/06/09 Peripherial vascular disease in diabetic patients on hemodialysis - risk of hospitalization and mortality in a large European cohort. S Brzosko, M Drozdz, J Frazão, W Kleophas, P Das, F Silva, S Jacobson “Poster”
Congress
2019/03/28 - 2019/03/30 Thrombotic microangiopathy and IGA nephropathy: is the complement system the missing link? H Diniz, M Bandeira, A Nunes, S Sampaio, P Pereira, F Gomes, J Coimbra, J Frazão, M Pestana. “Poster” apresentado no “”, Vilamoura, Portugal, 2019.
Congress
2018/11/29 - 2018/11/30 Renal osteodystrophy in peritoneal dialysis patients - an evolving disease? L Pereira, J Magalhães, C Carvalho, J Santos, C Meng, R Neto, A Oliveira, A Beco, J Frazão. “Poster”
Meeting
2018/10/23 - 2018/10/28 Etelcalcetide in the treatment of secondary hyperparathyroidism in patients uncontrolled with cinacalcet - results from a prospective study. A Weigert, M Amoedo, T Mendes, M Marques, C Meng, L Pereira, J Frazão. “Poster”
Congress
2018/10/23 - 2018/10/28 Patient satisfaction score in relation to hemodialysis guidelines and practices: a European multicenter analysis. M Drozdz, J Frazão, S Brzosko, F Silva, W Kleophas, A Alsuwaida, M Krishnan, S Jacobson. “Poster”
Congress
2018/10/23 - 2018/10/28 Achievement of KDIGO hemodialysis targets with ste<pwise increasing comorbidity burden: a European multicenter analysis. S Brzosko, J Frazão, M Drozdz, W Kleophas, A Alsuwaida, M Krishnan, S Jacobson. “Poster”
Congress
2018/10/23 - 2018/10/28 A European hemodialysis multicenter implementation of a standardized diabetic foot examination protocol. W Kleophas, M Drozdz, S Brzosko, J Frazão, F Silva, A Alsuwaida, M Krishnan, S Jacobson. “Poster”
Congress
2018/05/24 - 2018/05/24 Standardized clinical foot examination in prevalent diabetic hemodialysis patients - a European multicenter analysis. W Kleophas, J Frazão, S Brzosko, M Drozdz, A Alsuwaida, F Silva, S Sat, S Jacobson. “Poster”
Congress
2018/05/24 - 2018/05/24 A European multicenter analysis patient experiences and satisfaction - relation to practices and guidelines. M Drozdz, J Frazão, S Brzosko, W Kleophas, A Alsuwaida, F Silva, S Jacobson “Poster”
Congress
2018/03/22 - 2018/03/24 AA amyloidosis in a patient with breast cancer: report of a rare association. L Mendonça, H Ferreira, C Meng, H Diniz, A Nunes, M Damasceno, I Tavares, J Frazão, S Sampaio. “Poster”
Congress
2017/06/03 - 2017/06/06 Severe peripheral arterial disease in haemodialysis patients: a five centers study. I Godinho, F Silva, C Ferreira, M Amoedo, S Pedroso, A Azevedo, J Frazão, A Weigert. “Poster”
Congress
2017/06/03 - 2017/06/06 Bone histomorphometry data in renal transpant patients with hypercalcemic hyperparathyroidism with and without cinacalcet treatment. T Carvalho, C Carvalho, T Adragão, J Dickson, C Jorge, R Birne, A Weigert, M Bruges, P Matias, R Oliveira, A Casqueiro, J Frazão, D Machado. “Poster”
Congress
2017/04/06 - 2017/04/08 Peritonite a mycobacterium abscessus em doente em diálise peritoneal. H Ferreira, A Oliveira, A Beco, A Nunes, A Silva, J Frazão, M Pestana “Poster”
Congress
2017/04/06 - 2017/04/08 Ascite quilosa associada a terapêutica com lercanipina em doente submetida a colocação de cateter de diálise peritoneal. H Ferreira, A Oliveira, A Beco, A Nunes, J Frazão, M Pestana “Poster”
Congress
2016/11/15 - 2016/11/20 In uremic rats, the calcimimetic maintains bone turnover in a parathyroid hormone independent manner. J Tocados, M Ortiz, Y Peña, C Pineda, E Salido, V Lorenzo, C Carvalho, JM Frazão, J Munoz-Castaneda, E Aguilera-Tejero, M Rodriguez, O Lopez. “Poster”
Meeting
2016/05/21 - 2016/05/24 Bone disease characterization in a group of predialysis patients. R Neto, L Pereira, C Carvalho, J Magalhães, J Frazão “Poster”
Congress
2016/04/13 - 2016/04/16 Lesão renal aguda por uropatia obstrutiva sem hidronefrose bilateral. S Marques, C Ferreira, R Pinto, C Meng, J Frazão, M Pestana “Poster”
Congress
2016/04/13 - 2016/04/16 Nefropatia membranosa (idiopática?) tratada com regime Ponticelli numa doente com SIDA. L Pereira, C Meng, L Guedes, A Praça, J Frazão, M Pestana. “Poster”
Congress
2016/04/13 - 2016/04/16 Lesão renal aguda em 2 doentes com nefropatia de IGA. S Marques, H Diniz, H Ferreira, L Pereira, A Praça, J Frazão, M Pestana. “Poster”
Congress
2015/05/28 - 2015/05/31 Phosphate restriction preserves bone volume in early and late stages of CKD in Rats. Díaz-Tocados JM, Rodríguez-Ortiz ME, Herencia1 C, Martínez-Moreno1 JM, Montes de Oca1 A, Vergara1 N, Carvalho CG, Rodríguez M, Frazão JM, Almadén Y, Muñoz-Castañeda1 JR. “Poster”
Congress
2014/05/31 - 2014/06/03 Treatment of Pauci-Imune vasculitis with a reduced IV cyclophosphamide Regimen. Nunes A, Ferreira I, Neto R, Mariz E, Pereira E, Frazão J, Praça A, Sampaio S, Pestana M. “Poster”
Congress
2009/05/22 - 2009/05/26 Renal biopsy in the elderly: is it worth the risk? Carvalho C, Neto R, Sampaio S, Frazão J, Pestana M. “Poster”
Congress
2008/05/10 - 2008/05/13 Hemoglobin stability in chronic kidney disease hemodialysis patients switched from darbepoetin-alfa to epoetin-beta. Neto R, Frazão JM, Silva M, Fazendeiro J, Serafim M, Pinheiro J, Mota M, Martins C, Sarmento M. “Poster”
Congress
2008/05/10 - 2008/05/13 25-hydroxivitamnin D deficiency: a new cardiovascular risk factor in hemodialysis patients? Adragão T, Ferreira A, Frazão JM, Faugere MC, Malluche HH. “Poster”
Congress
2007/06/21 - 2007/06/24 Bone mineral density, bone histomorphometric analysis and vascular calcifications in hemodialysis patients. Adragão T, Ferreira A, Frazão JM, Gil C, Oliveira C, Galvão J, Sarmento M, Ribeiro S, Dickson J, Carvalho B, Rodrigues I, Baldaia J, Pereira O, Faugere MC, Malluche HH. “Poster”
Conference
2007/06/21 - 2007/06/24 A plain X-ray vascular calcification score predicts coronary agatston score in hemodialysis patients. Adragão T, Ferreira A, Frazão JM, Gil C, Oliveira C, Galvão J, Sarmento M, Ribeiro S, Dickson J, Carvalho B, Rodrigues I, Baldaia J, Pereira O. “Poster”
Congress
2006/07/15 - 2006/07/18 The OPTIMA study: Lower doses of cinacalcet (Mimpara®/Sensipar®) are required to achieve KDOQITM secondary hyperparathyroidism (HPT) targets in dialysis patients with less severe disease. Messa P, Villa G, Braun J, Maduell F, Cruz J, Martin PY, Kovarik J, Saha H, Zani V, Carter D, Molemans B, Frazão JM. “Poster”
Congress

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2019/09/01 Experimental chronic renal failure: fibrosis, cardiovascular and bone mineral metabolism alterations. New therapeutic perspectives
(Thesis) Arguer
 Laura Martínez Arias (PhD)
2019/01/02 Advances in the role of the microbiome in peritoneal dialysis
Thesis Member
 Liliana Carina Simões Silva (PhD)
2017/11/02 Interplay between osteoblasts, osteoclasts and afferent nerves: untying the molecular mechanisms behind the bone innervation
Thesis Member
 Estrela do Céu Neto (PhD)
2015/10/01 Renal function and dammage in acute heart failure – A place for new and old biomarkers
(Thesis) Arguer
 Margarida Isabel Ribeiro de Cavadas Pereira e Alvelos (PhD)
2015/06/02 Avaliação económica em transplantação renal. Abordagem estratégica do processo de doação e análise do custo – utilidade do programa de transplantação renal versus hemodiálise
(Thesis) Arguer
 Maria Margarida Brito de Almeida Oliveira Domingos (PhD)
2015/06/01 Privacidade na prática de cuidar a pessoa em programa regular de hemodiálise
Thesis Member
 Cristina Maria Medeiros Guedes Ferreira de Moura (PhD)
2015/05/01 Modulação do sistema dos peptídeos natriuréticos na doença renal crónica
Thesis Member
 Carla Alexandra Ribeiro dos Santos Araújo (PhD)
2015/03/01 Transplante duplo de rim e pâncreas: evolução clínica e metabólica e significado da expressão de autoimunidade anti-ilhota pancreática
Thesis Member
 Maria de La Salete Soares Martins da Silva (PhD)
2013/02/01 Patologia óssea do insuficiente renal crónico: desafio clínico-biológico; caracterização da osteodistrofia renal e efeitos da biocompatibilidade de membranas de hemodiálise, na remodelação óssea
(Thesis) Arguer
 Manuel Aníbal Antunes Ferreira (PhD)
2012/12/02 Conhecimentos, adesão e barreiras ao tratamento da hiperfosfatemia em insuficientes renais crónicos em programa regular de hemodiálise
(Thesis) Arguer
 Catarina Arnaldina Mourão Silva Vieira Dias (Master)
2012/06/01 Estudo da atividade eferente do sistema nervoso autónomo na nefrolitíase recorrente
(Thesis) Arguer
 Fernando Manuel Pinto Ferreira Domingos (PhD)
2012/04/01 O Metabolismo fosfo-cálcico na doença renal crónica: identificação de mecanismos fisiopatológicos a partir de dados epidemiológicos
Thesis Member
 Ana Lorena dos Santos Pires Mariquitos (PhD)
2011/11/02 Calcificações vasculares nos doentes em diálise: elo de ligação entre doença óssea e doença vascular
Thesis Member
 Maria Teresa Filipe Nunes da Silva Pulido Adragão (PhD)
2010/11/02 Necessidades básicas da pessoa com insuficiência renal crónica – vivências no percurso da doença
(Thesis) Arguer
 Hernâni Ferreira Cabral (Master)
2008/06/01 Inflamação na Doença Renal Crónica
Thesis Member
 José Pedro Castro Leão Neves (PhD)
2004/03/01 Aportaciones A la Etiopatogenia, Diagnóstico y Tratamento de La Osteodistrofia Renal
(Thesis) Arguer
 Maria Del Carmen Diaz Corte (PhD)

Association member

Society Organization name Role
2004/01/01 - 2010/12/31 Sociedade Portuguesa de Nefrologia durante dois mandatos de 3 anos (2004 a 2010). Vice-Presidente
2005/01/01 - 2008/12/31 European Renal Association-European Dialysis and Transplant Association Council Member

Committee member

Activity description
Role 		Institution / Organization
2017/01/01 - 2019/12/31 European Renal Association-European Dialysis and Transplant Association, Chronic Kidney Disease-Mineral and Bone Disorders Working Group Advisor
Advisor / Consultant

Conference scientific committee

Conference name Conference host
2022/01/01 - 2022/03/31 Membro do Paper Selection Committee do 59th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress maio de 2022. Paris, França
2021/01/01 - 2021/03/31 Membro do Paper Selection Committee do 58th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress Berlim, Alemanha
2020/01/01 - 2020/03/31 Membro do Paper Selection Committee do 57th European Renal Association -European Dialysis and Transplant Association (ERA-EDTA) Congress Milão, Itália
2019/01/01 - 2019/03/31 Membro do “Paper Selection Committee” do “56th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Budapeste, Hungria
2018/01/01 - 2018/03/31 Membro do “Paper Selection Committee” do “55th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Copenhaga, Dinamarca
2017/01/01 - 2017/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “54th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Madrid, Espanha
2016/01/01 - 2016/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “53th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Viena, Áustria
2015/01/01 - 2015/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “52th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Londres, Reino Unido
2014/01/01 - 2014/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “51th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Amesterdão, Holanda
2013/01/01 - 2013/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “50th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress Istambul, Turquia
2012/01/01 - 2012/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “49th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Paris, França
2012/01/01 - 2012/03/31 Membro do “Scientific Committee” do “49th European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) Congress” Paris, França
2011/01/01 - 2011/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “XLVIII European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Praga, Republica Checa
2010/01/01 - 2010/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “XLVII European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Munique, Alemanha
2008/01/01 - 2008/03/31 Membro do “Paper Selection Committee as Section Chair on the topic Bone Disease in Dialysis Patients” do “XLV European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress” Estocolmo, Suécia
2007/01/01 - 2007/03/31 Membro do “Paper Selection Committee” do “XLIV European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) Congress” Barcelona, Espanha
2006 - 2006/03/31 Membro do “Paper Selection Committee” do “XLIII European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) Congress” Glasgow, Reino Unido
2005/01/01 - 2005/03/31 Membro do “Paper Selection Committee” do “XLII European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) Congress” Istambul, Turquia
2004/01/01 - 2004/03/31 Membro do “Paper Selection Committee” do “XLI European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) Congress” Lisboa, Portugal
Distinctions

Award

2020 Prémio Fresenius/Sociedade Portuguesa de Nefrologia
2015 Bolsa de estudos em autoimunidade NEDAI 2015 - Mechanisms involved in endotelium damage in lupus nephritis
2014 Bolsa de Investigação da Sociedade Portuguesa de Nefrologia
2007 Prémio Sociedade Portuguesa de Nefrologia/Roche, destinado anualmente a premiar os trabalhos não publicados com o objectivo de incentivar o interesse dos nefrologistas portugueses pela investigação.
2001 Bolsa Janssen-Cilag / Sociedade Portuguesa de Nefrologia
1998 Prémio Fresenius/Sociedade Portuguesa de Nefrologia para o melhor artigo publicado por um membro da Sociedade Portuguesa de Nefrologia em revistas de nefrologia estrangeiras com prestígio internacional reconhecido
1998 Prémio - Melhor Artigo de Revisão publicado na Revista Portuguesa de Nefrologia e Hipertensão

Title

2013 Distinguished Fellow of the European Renal Association-European Dialysis and Transplantation Association
European Renal Association European Dialysis and Transplant Association, Italy
2005 “XIX Congresso Português de Nefrologia” - Prémio melhor comunicação oral na área de nefrologia clínica pela Sociedade Portuguesa de Nefrologia.